Octave Announces Publication of Analytical Validation Study Results in Nature Communications More

Our Science

Powerful innovation to transform MS

We're committed to rigorous and ongoing evaluation.

Browse our latest publications below.

Category

1 … 5 6 7 … 9

Differential Diagnosis Of MS Patients Versus Disease State Controls and Classification of MS Subtypes Using Serum Proteomics

Research Presented at the Annual ECTRIMS Meeting - October 26-28, 2022

Multiple Sclerosis MRI Reports Vary Among Neuroradiologists

Research Presented at the Annual ECTRIMS Meeting - October 26-28, 2022

Longitudinal Testing with a Multivariate Blood Serum Biomarker Panel for Multiple Sclerosis Disease Activity: Patterns of Results in a Real-World Clinical Setting

Research Presented at the Annual ECTRIMS Meeting - October 26-28, 2022

Matched Plasma Modification for Calculating a Disease Activity Score in a Serum-Validated Multivariate Proteomic Multiple Sclerosis Disease Activity Test

Research Presented at the Annual ECTRIMS Meeting - October 26-28, 2022

Study Design: The Impact of Quantitative Structured MRI Reports on Clinical Decision Making in MS

Research Presented at the Annual ECTRIMS Meeting - October 26-28, 2022

Tracking Longitudinal Change in Brain Volumes through Conditional Quantiles

Research Presented at the Annual ECTRIMS Meeting - October 26-28, 2022

Serum Biomarkers of Progression by Proteomic Search in Extreme MS Phenotypes

Research Presented at the Annual ECTRIMS Meeting - October 26-28, 2022

Blood Serum Proteome Correlates of Multiple Sclerosis Disease Progression as evaluated by Clinical and Brain Atrophy Outcomes: A 5-Year Longitudinal Study

Research Presented at the Annual ECTRIMS Meeting - October 26-28, 2022

Clinical Phenotypes from Blood Serum Protein Concentration

Research Presented at the Annual ECTRIMS Meeting - October 26-28, 2022

Multivariate Proteomic Analysis and the Relationship with Axonal Pathology in Multiple Sclerosis: A Longitudinal 5-Year Diffusion Tensor Imaging Study

Research Presented at the Annual ECTRIMS Meeting - October 26-28, 2022